Target intelligence / Profile preview

Elongin B pseudogene 2 (ELOBP2)

Target
ELOBP2
Molecular classification
Pseudogene
01

Overview

Elongin B pseudogene 2 (ELOBP2, also known as TCEB2P2) is a human pseudogene related to the Elongin B gene (TCEB2). Pseudogenes are DNA sequences similar to functional genes but are typically non-functional due to mutations or deletions, and they are usually not transcribed into functional proteins. ELOBP2 does not code for a protein product and is not involved in canonical biological pathways, disease processes, or targeted pharmacology[4][5][6]. Key context: - ELOBP2 is a pseudogene and not a protein-coding gene or a functional receptor, enzyme, or other druggable target[5][6]. - It shares sequence similarity with the functional Elongin B gene, which is involved in transcription elongation and ubiquitination pathways; however, ELOBP2 does not have a known biological function[4][5][6]. - Because it is a pseudogene, there are no known drugs, disease associations, mechanisms of drug action, biomarker roles, or safety concerns[5][6]. - Listings in standard gene databases and gene compendia confirm this pseudogene status, distinguishing it from the functional Elongin B (ELOB), which is a regulatory protein in key complexes[5][6][4]. Thus, **ELOBP2 is not a functional therapeutic target**, and its primary relevance is in genomics rather than molecular or clinical pharmacology[5][6].

Other names
TCEB2P2Transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) pseudogene 2Elongin B pseudogene 2Transcription elongation factor B subunit 2 pseudogene 2Transcription elongation factor B (SIII), polypeptide 2 (18kD, elongin B) pseudogene

Beyond the preview

Go deeper on Elongin B pseudogene 2 (ELOBP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongin B pseudogene 2 (ELOBP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call